SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-080680
Filing Date
2020-03-20
Accepted
2020-03-20 16:18:32
Documents
4
Period of Report
2020-03-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d883732d8k.htm 8-K 25993
2 EX-10.1 d883732dex101.htm EX-10.1 21729
3 EX-10.2 d883732dex102.htm EX-10.2 32905
4 EX-10.3 d883732dex103.htm EX-10.3 126579
  Complete submission text file 0001193125-20-080680.txt   208497
Mailing Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210 617-207-0202
AKCEA THERAPEUTICS, INC. (Filer) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38137 | Film No.: 20732195
SIC: 2834 Pharmaceutical Preparations